Malaria Ag Rapid Testing Market size is projected to surpass USD 59 Billion by the end of 2036, growing at a CAGR of over 5% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of malaria ag rapid testing was USD 36 Billion. This market is poised to rise on account of the growing prevalence of malaria. According to the World Health Organization, in comparison to 244 million cases in 2021, there were a total of 249 million cases of malaria in 2022, according to the most recent World Malaria Report. The predicted number of malaria deaths stood to 608 000 in 2022 compared to 610 000 in 2021. Hence, the market demand for malaria ag rapid testing is poised to rise.
Furthermore, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae are the four different types of malaria parasites that affect humans. However, it is estimated that more different types of malaria are set to become prevalent in the coming years. Therefore, the need for malaria ag rapid testing is poised to surge in the coming years.
Growth Drivers
Challenges
Base Year |
2023 |
Forecast Year |
2024-2036 |
CAGR |
~5% |
Base Year Market Size (2023) |
~ USD 36 Billion |
Forecast Year Market Size (2036) |
~ USD 59 Billion |
Regional Scope |
|
Distribution Channel (Drugstore, Retail Pharmacy, Hospital Chain Pharmacy, Online Pharmacy)
The hospital chain pharmacy segment in the malaria ag rapid testing market is set to gather the highest share of about 40% during the forecast period. This growth is set to be influenced by growth in number of hospitals. The number of hospitals worldwide as of 2021 is estimated to be over 164,000. Hospitals serve a vital role in the struggle over malaria, given their ability to deal with a wide range of medical ailments, particularly severe cases of the illness. Since RDTs are dependable and precise, patients receive swift and accurate diagnoses in hospital settings. This is why they are preferred. In addition, hospitals frequently act as referral hubs for patients from different areas seeking care, so having access to quick and accurate diagnostic tests is crucial. Furthermore, the widespread use of hospitals and the crucial role that clinics play in treating and diagnosing malaria indicate a comprehensive approach to the disease. The collaborative effort between these healthcare settings emphasizes the need of customized diagnostic approaches for a range of end users and shows promise for more successful malaria control.
Product Type (Dipsticks, Cassette)
Malaria ag rapid testing market from the dipstick segment is estimated to gather the highest share of about 60% during the forecast period. This could be since, researchers came to the judgment that, if nonspecialized laboratories are engaged, dipsticks offer the potential to improve the specific accuracy of the diagnosis of P. falciparum malaria based on the specificity and sensitivity achieved. Furthermore, since they are portable, dipstick instruments provide on-site testing for the identification of tampered specimens. This major advantage has led to an abundance of commercially available devices. Moreover, the cost of the dipstick is relevantly low which adds to its demand. These typically entail attaching chemically treated pads to plastic strips, each pad serving as an assay for a distinct characteristic of the object. Since they are portable, dipstick instruments provide on-site testing for the identification of tampered specimens. This major advantage has led to an abundance of commercially available devices. These typically entail attaching chemically treated pads to plastic strips, each pad serving as an assay for a distinct characteristic of the object.
Our in-depth analysis of the global market includes the following segments:
Product Type |
|
Distribution Channel |
|
North American Market Forecast
The North America malaria ag rapid testing market is estimated to hold 30% of the revenue share by 2036. This growth is set to be dominated by rising travelers returning to North America. Furthermore, with about 45% of US corporate travelers doing more trips than they did prior to the epidemic, business travel is returning. However, this has further led to an increase in malaria cases. Most of the people in North America visit regions such as the Middle East & Africa which is the hotspots for malaria prevalence. Hence, these travelers return back with the infection hence boosting the malaria rate. Every year, travel to malaria-endemic regions including sub-Saharan Africa, parts of South America, and Southeast Asia is linked to between 1,999 and 2,500 cases of malaria in the country; nevertheless, over 8 locally transmitted cases this year have been reported by individuals who haven't recently visited these regions. There were about 6 instances reported in Florida and one in each of Maryland and Texas. Hence, it has also been estimated that this region has recorded its first homegrown malaria cases. Therefore, the market for malaria ag rapid testing market is set to rise in this region.
European Market Analysis
The malaria ag rapid testing market in Europe is also expected to experience significant growth over the forecast period. Fifty years after being eradicated, malaria remains a serious health threat in Europe. Furthermore, there has been rigorous launch of vaccines in this region by various key players and number of researches has taken place in order to eradicate completely. As a result, this market is poised to grow in this region.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?